Holen Sie sich die Stockscreener-App
18.38
0.33%
-0.06
Handel nachbörslich:
18.38
Schlusskurs vom Vortag:
$18.44
Offen:
$18.41
24-Stunden-Volumen:
649.74K
Relative Volume:
0.87
Marktkapitalisierung:
$1.50B
Einnahmen:
$305.00K
Nettoeinkommen (Verlust:
$-328.98M
KGV:
-4.799
EPS:
-3.83
Netto-Cashflow:
$-309.60M
1W Leistung:
-4.40%
1M Leistung:
+9.47%
6M Leistung:
+20.21%
1J Leistung:
+22.53%
1-Tages-Spanne:
$18.00
$18.58
1-Wochen-Bereich:
$18.00
$19.73
52-Wochen-Spanne:
$9.90
$27.20
Viridian Therapeutics Inc Stock (VRDN) Company Profile
Firmenname
Viridian Therapeutics Inc
Sektor
Branche
Telefon
617.272.4600
Adresse
221 CRESCENT STREET, WALTHAM
Vergleichen Sie VRDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRDN
Viridian Therapeutics Inc
|
18.38 | 1.51B | 305.00K | -328.98M | -309.60M | -3.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Fortgesetzt | Jefferies | Buy |
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-25 | Eingeleitet | TD Cowen | Buy |
| 2024-09-11 | Bestätigt | Needham | Buy |
| 2024-06-11 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-05-09 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-05-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2023-06-14 | Eingeleitet | BTIG Research | Buy |
| 2023-06-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-04-17 | Eingeleitet | Wells Fargo | Overweight |
| 2023-03-30 | Eingeleitet | Stifel | Buy |
| 2022-12-19 | Eingeleitet | Cowen | Outperform |
| 2022-12-19 | Eingeleitet | Needham | Buy |
| 2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
| 2022-12-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-01-25 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Viridian Therapeutics Inc Aktie (VRDN) Neueste Nachrichten
Viridian Therapeutics Inc. stock trend outlook and recovery pathTrade Risk Summary & Short-Term High Return Ideas - Newser
Detecting price anomalies in Viridian Therapeutics Inc. with AIPortfolio Value Summary & Daily Stock Trend Watchlist - Newser
Published on: 2025-08-30 12:01:20 - Newser
Live market analysis of Viridian Therapeutics Inc.Swing Trade & Reliable Volume Spike Alerts - Newser
Viridian Therapeutics Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - thegnnews.com
How to interpret RSI for Viridian Therapeutics Inc. stockMarket Sentiment Review & Safe Capital Preservation Plans - Newser
Measuring Viridian Therapeutics Inc.’s beta against major indicesQuarterly Profit Review & Real-Time Buy Signal Notifications - Newser
Combining price and volume data for Viridian Therapeutics Inc.July 2025 WrapUp & Expert Curated Trade Setup Alerts - Newser
What data driven models say about Viridian Therapeutics Inc.’s future2025 Market Overview & Daily Risk Controlled Trade Plans - Newser
Applying big data sentiment scoring on Viridian Therapeutics Inc.Buy Signal & Community Verified Watchlist Alerts - Newser
Has Viridian Therapeutics Inc. found a price floorJuly 2025 Patterns & Stock Portfolio Risk Management - Newser
Published on: 2025-08-29 14:30:40 - Newser
Will Viridian Therapeutics Inc. see short term momentumQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-08-29 11:41:18 - Newser
Viridian Therapeutics Inc. Matches Institutional Buying Filter2025 Dividend Review & Real-Time Volume Spike Alerts - beatles.ru
Has Viridian Therapeutics Inc. formed a bullish divergencePortfolio Gains Report & Proven Capital Preservation Methods - Newser
What recovery options are there for Viridian Therapeutics Inc.Inflation Watch & Weekly Momentum Stock Picks - Newser
Published on: 2025-08-27 20:10:20 - Newser
Analyzing Viridian Therapeutics Inc. with multi timeframe chartsFed Meeting & Daily Market Momentum Tracking - Newser
Using R and stats models for Viridian Therapeutics Inc. forecasting2025 Pullback Review & Risk Controlled Daily Plans - Newser
Leading vs lagging indicators on Viridian Therapeutics Inc. performanceJuly 2025 Levels & Reliable Breakout Forecasts - Newser
How to forecast Viridian Therapeutics Inc. trends using time seriesMarket Sentiment Summary & Daily Chart Pattern Signal Reports - Newser
Statistical indicators supporting Viridian Therapeutics Inc.’s strengthJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
What earnings revisions data tells us about Viridian Therapeutics Inc.July 2025 Earnings & Smart Money Movement Alerts - Newser
Is Viridian Therapeutics Inc. Forming a Bottom Pattern2025 Valuation Update & Consistent Income Trade Ideas - beatles.ru
Published on: 2025-08-26 03:10:40 - sundaytimes.kr
Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):